TELA Insider Trading

Insider Ownership Percentage: 6.00%
Insider Buying (Last 12 Months): $409,995.00
Insider Selling (Last 12 Months): $1,855,836.00

TELA Bio Insider Trading History Chart

This chart shows the insider buying and selling history at TELA Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal Insider BuyingTotal Insider Selling

TELA Bio Share Price & Price History

Current Price: $1.24
Price Change: Price Decrease of -0.135 (-9.85%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for TELA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$1.24Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for TELA Bio (NASDAQ:TELA)

94.35% of TELA Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TELA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$10Mbought$314ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal InflowsTotal Outflows
TELA Bio logo
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Read More on TELA Bio

Today's Range

Now: $1.24
Low: $1.23
High: $1.35

50 Day Range

MA: $2.42
Low: $1.24
High: $2.88

52 Week Range

Now: $1.24
Low: $1.15
High: $6.50

Volume

222,311 shs

Average Volume

225,807 shs

Market Capitalization

$48.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Who are the company insiders with the largest holdings of TELA Bio?

TELA Bio's top insider shareholders include:
  1. Orbimed Advisors Llc (Major Shareholder)
  2. Antony Koblish (CEO)
  3. Roberto Cuca (CFO)
  4. Paul Talmo (CTO)
  5. Gregory A Firestone (Insider)
Learn More about top insider investors at TELA Bio.

Who are the major institutional investors of TELA Bio?

TELA Bio's top institutional shareholders include:
  1. Silverarc Capital Management LLC — 7.78%
  2. AIGH Capital Management LLC — 6.76%
  3. Stonepine Capital Management LLC — 5.97%
  4. DAFNA Capital Management LLC — 3.66%
  5. Royce & Associates LP — 2.54%
  6. Pentwater Capital Management LP — 2.54%
Learn More about top institutional investors of TELA Bio stock.

Which institutional investors are selling TELA Bio stock?

During the previous quarter, TELA stock was sold by these institutional investors:
  1. Landscape Capital Management L.L.C.
  2. Millennium Management LLC
  3. Bridgeway Capital Management LLC
  4. Citadel Advisors LLC

Which institutional investors are buying TELA Bio stock?

In the last quarter, TELA stock was bought by institutional investors including:
  1. Silverarc Capital Management LLC
  2. DAFNA Capital Management LLC
  3. Stonepine Capital Management LLC
  4. Royce & Associates LP
  5. Perkins Capital Management Inc.
  6. Pentwater Capital Management LP
  7. Mink Brook Asset Management LLC
  8. Renaissance Technologies LLC
In the last year, these company insiders have bought TELA Bio stock:
  1. Orbimed Advisors Llc (Major Shareholder)
  2. Antony Koblish (CEO)
  3. Roberto Cuca (CFO)
  4. Paul Talmo (CTO)
Learn More investors buying TELA Bio stock.